Physiological plasminogen activators of tissue and urokinase type (serine proteinases) are effective thrombolytic agents. Research and development of their novel forms contributed to progress of thrombolytic therapy, advanced treatment of acute coronary syndrome and a marked decrease in the lethal index.
Download PDF:
Keywords: serine proteinases, tissue and urokinase type plasminogen activators, thrombosis, acute coronary syndrome, thrombolysis, reperfusion
Citation:
Maksimenko A.V. (2014) Thrombolysis with plasminogen activators: use and research of serine proteinases, promise and actuality. Biomeditsinskaya Khimiya, 60(6), 677-682.
et al. Thrombolysis with plasminogen activators: use and research of serine proteinases, promise and actuality // Biomeditsinskaya Khimiya. - 2014. - V. 60. -N 6. - P. 677-682.
et al., "Thrombolysis with plasminogen activators: use and research of serine proteinases, promise and actuality." Biomeditsinskaya Khimiya 60.6 (2014): 677-682.
Maksimenko, A. V. (2014). Thrombolysis with plasminogen activators: use and research of serine proteinases, promise and actuality. Biomeditsinskaya Khimiya, 60(6), 677-682.
Huber K., Goldstein P., Danchin N., Fox K.A., Welsh R., Granger C.B., Henry T., Gersh B.J. (2013)Am. Heart J., 165, 123-132. CrossRef Scholar google search
